Skip to main content
OpenTrials
Completed

NCT Number: NCT06134726

Temporomandibular Joint in Patients With Rheumatoid Arthritis

the investigators study aimed to evaluate temporomandibular joint involvement in rheumatoid arthritis patients and healthy individuals 142 participants were recruited in two groups: 72 patients with Rheumatoid Arthritis (RA), and 70 healthy controls. All participants were tested for seropositivity of rheumatoid factor and anticitrullinated protein antibodies. TMD diagnosis was determined according to the standardized and validated diagnostic criteria for TMD (DC/TMD): myalgia, arthralgia, articular disc, displacement, degenerative joint disease, and headache attributed to TMD. Bruxism, a probable sleep and/or awake bruxism diagnosis was determined based on self-report and several clinical findings.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Temporomandibular Joint Disorders Arthritis Arthritis, Rheumatoid Autoimmune Diseases Behavior Bruxism Connective Tissue Diseases Craniomandibular Disorders Habits Immune System Diseases Jaw Diseases Joint Diseases Mandibular Diseases Muscular Diseases Musculoskeletal Diseases Rheumatic Diseases Rheumatoid Arthritis Skin and Connective Tissue Diseases Stomatognathic Diseases Tooth Diseases

Age range

35 year–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of Medicine, Damascus University, Syria

Damascus, 1, Syria

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

  • Inclusion criteria included:
  • age > 18 years old
  • individuals who had a minimum of 12 natural teeth.
  • Exclusion criteria
  • included: trauma or surgery on the jaw
  • facial nerve paralysis
  • tooth implant
  • scleroderma
  • cerebrovascular accident
  • schizophrenia
  • steroid injection within the last six months.

Treatment and study plan

seropositivity of rheumatoid factor

Diagnostic Test

All participants were tested for seropositivity of rheumatoid factor and anticitrullinated protein antibodies

Other names: anticitrullinated protein antibodies

Primary outcomes

  1. Number of patients with prevalence of TMD

    Time frame: 2 years

    patients were interviewed, filled out the questionnaire, and examined

  2. Number of patients with TMD-pain diagnoses

    Time frame: 2 years

    patients were interviewed, filled out the questionnaire, and examined

Sponsors and collaborators

Lead sponsor

Syrian Private University

Other

Registry information

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Nov 18, 2023
Registry last updated
Nov 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.